Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Imai

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cancer|May 20, 2022
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumorsMasatoshi Takagi, Chitose Ogawa, Tomoko Iehara, et al.
Journal of Medicinal Chemistry|July 4, 2012
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approachTomomi Kosugi, Dale R Mitchell, Aiko Fujino, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cancer|May 20, 2022
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumorsMasatoshi Takagi, Chitose Ogawa, Tomoko Iehara, et al.
Journal of Medicinal Chemistry|July 4, 2012
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approachTomomi Kosugi, Dale R Mitchell, Aiko Fujino, et al.
Pageof 2